Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms

American Journal of Surgery

Volumn 191, Issue 6, 2006, Pages 743-748

  Sperti, Cosimo ^a   Pasquali, Claudio ^a,b   Fiore, Vittorio ^c   Bissoli, Sergio ^c   Chierichetti, Franca ^c   Liessi, Guido ^c   Pedrazzoli, Sergio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Ospedale Giustinianeo   (Italy)

^c Castelfranco Hospital   (Italy)

Author keywords

Ampullary cancer; Bile duct cancer; Follow up; Pancreatectomy; Periampullary neoplasms; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BILE DUCT TUMOR; CANCER RECURRENCE; CLINICAL ARTICLE; COLON TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUODENUM TUMOR; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; PANCREAS BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VATER PAPILLA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; BILE DUCT NEOPLASMS; DUODENAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LAPAROTOMY; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 33646571206     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.03.042     Document Type: Article

References (30)

1. Sarmiento J.M., Nagorney D.M., Sarr M.G., et al. Periampullary cancers. Are there differences?. Surg Clin North Am 81 (2001) 543-555
2. Yeo C.J., Cameron J.L., Sohn T.A., et al. Six hundred fifty consecutive pancreatoduodenectomies in the 1990s; pathology, complications, and outcomes. Ann Surg 226 (1997) 248-257
3. Sperti C., Pasquali C., Piccoli A., et al. Radical resection for ampullary carcinoma. long-term results. Br J Surg 81 (1994) 668-671
4. Yeo C.J., Sohn T.A., Cameron J.L., et al. Periampullary adenocarcinoma. Analysis of 5-year survivors. Ann Surg 227 (1998) 821-831
5. Schwarz M., Pauls S., Sokiranski R., et al. Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective?. Am J Surg 182 (2001) 243-249
6. Menack M.J., Spitz J.D., and Arregui M.E. Staging of pancreatic and ampullary cancers for resectability using laparoscopy with laparoscopic ultrasound. Surg Endosc 15 (2001) 1129-1134
7. Sugita R., Furuta A., Ito K., et al. Periampullary tumors. high-spatial-resolution MR imaging and histopathologic findings in ampullary region specimens. Radiology 231 (2004) 767-774
8. Hustinx R., Benard F., and Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med 32 (2002) 35-46
9. Pham K.H., Ramaswamy M.R., and Hawkins R.A. Advances in positron emission tomography imaging for the GI tract. Gastrointest Endosc 55 Suppl 7 (2002) 553-563
10. Van Hertum R.L., and Fawvaz R.A. The role of nuclear medicine in the evaluation of pancreatic disease. Surg Clin North Am 8 (2001) 345-358
11. Sperti C., Pasquali C., Chierichetti F., et al. 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma. J Gastrointest Surg 7 (2003) 953-960
12. Kalady M.F., Clary B.M., Clark L.A., et al. Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. Ann Surg Oncol 9 (2002) 799-806
13. Sperti C., Pasquali C., Chierichetti F., et al. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg 234 (2001) 675-680
14. Bar-Shalom R., Valdivia A.Y., and Blaufox A.D. PET imaging in oncology. Semin Nucl Med 30 (2000) 150-185
15. Friess H., Langhans J., Ebert M., et al. Diagnosis of pancreatic cancer by 2(18F)-fluoro-2-deoxy-D-glucose positron emission tomography. Gut 36 (1995) 771-777
16. Kluge R., Schmidt F., Caca K., et al. Positron emission tomography with (18F)fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer. Hepatology 33 (2001) 1029-1035
17. Duffy J.P., Hines O.J., Liu J.H., et al. Improved survival for adenocarcinoma of ampulla of Vater. Fifty-four consecutive resections. Arch Surg 138 (2003) 942-950
18. Jadvar H., and Fischman A.J. Evaluation of pancreatic carcinoma with FDG PET. Abdom Imaging 26 (2001) 254-259
19. Clarke D.I., Thomson S.R., Madiba T.F., et al. Preoperative imaging of pancreatic cancer. a management-oriented approach. J Am Coll Surg 196 (2003) 119-129
20. Sendler A., Avril N., Heinberger H., et al. Preoperative evaluation of pancreatic masses with positron emission tomography using F-fluorodeoxyglucose. diagnostic limitation. World J Surg 24 (2000) 1121-1129
21. Karsperk R.K., Riesener K.-P., Wilms K., et al. Limited value of positron emission tomography in treatment of pancreatic cancer. surgeon's view. World J Surg 25 (2002) 975-982
22. Lindell G., Borch K., Tingstedt B., et al. Management of cancer of the ampulla of Vater. does local resection play a role?. Dig Surg 20 (2003) 511-515
23. Simò M., Lomena F., Setoain J., et al. FDG-PET improves the management of patients with suspected recurrence of colorectal cancer. Nucl Med Commun 23 (2002) 975-982
24. Meyerhardt J.A., and Meyer R.S. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol 30 (2003) 349-360
25. Belhocine T. An appraisal of 18F- FDG PET imaging in post-therapy surveillance of uterine cancers. clinical evidence and a research proposal. Int J Gynecol Cancer 13 (2003) 228-233
26. Rose M.D., Delbeke D., Beauchamp R.D., et al. 18-fluorodeoxyglucose positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 229 (1998) 729-738
27. Franke C., Klapdor R., Miyerhoff K., et al. 18-FDG positron emission tomography of the pancreas. diagnostic benefit in the follow-up of pancreatic carcinoma. Anticancer Res 19 (1999) 2437-2442
28. Kim J.K., Ha H.K., Han D.J., et al. CT analysis of postoperative tumor recurrence patterns in periampullary cancer. Abdom Imaging 28 (2003) 384-391
29. Robertson J.F.R., Boyle P., and Imrie C.W. Patients with ampullary carcinoma are prone to other malignant tumours. Br J Surg 58 (1988) 216-218
30. Bar-Shalom R., Yefremov N., Guralnik L., et al. Clinical performance of PET/CT in evaluation of cancer. additional value for diagnostic imaging and patient management. J Nucl Med 44 (2003) 1200-1209